Tue May 3 16:40:02 SGT 2016  
SINGAPORE
SEXUALHEALTH™
    Hiv
SINGAPORE SEXUALHEALTH™
HIV PEP (post-exposure prophylaxis): Stop HIV infection within 3 days after unprotected sex.
HIV test: 20 minute rapid test to accurately detect HIV infection 28 days after unprotected sex.
STD testing: Full & comprehensive sexually transmitted disease testing.

Hiv | SINGAPORE SEXUALHEALTH™

Summary

Hiv | SINGAPORE SEXUALHEALTH™ @singaporesexualhealth_com: , Singapore. Private & confidential service.

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
SINGAPORE SEXUALHEALTH™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: www.shimclinic.com
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Description

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception (females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing.
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception (females only)
2 weeks HIV DNA PCR test
1 month 20 minute rapid HIV test - SD Bioline HIV Ag/Ab Combo:
- Fingerprick blood sampling.
3 months 20 minute rapid HIV test - OraQuick®:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

The challenge of opportunistic infections: Focus on South America
Tue, 29 Mar 2016 09:23:41 +0100 | International Journal of Infectious Diseases
Abstract: Some opportunistic diseases are either exclusive or more commonly observed in South American AIDS patients than in those from different parts of the world. Interactions between HIV and endemic parasitic and other locally prevalent pathogens occur frequently in South America. However, knowledge about the impact of these interactions has been accumulating only recently. (Source: International Journal of Infectious Diseases)

Challenges in the management of opportunistic infections: Focus on Southeast Asia
Tue, 29 Mar 2016 09:23:41 +0100 | International Journal of Infectious Diseases
Abstract: Late presenters into HIV care remain common in South East Asia. In an analysis of more than 3700 patients in an Asian observational cohort, more than 72% were late presenters ie presenting into HIV care for the first time with CD4 of < 200 cells/mm3 or with an AIDS defining illness. Consequently physicians in South East Asia continue to manage patients who present with a myriad of opportunistic infections including toxoplasmosis, CMV infection, disseminated fungal infections and tuberculosis. (Source: International Journal of Infectious Diseases)

The long-term impact of antiretroviral therapy in resource-limited settings
Tue, 29 Mar 2016 09:23:40 +0100 | International Journal of Infectious Diseases
Abstract: With the advent of antiretroviral therapy (ART), HIV has shifted to a chronic manageable condition, even in resource-limited settings. Now, the long-term effects of being on ART and living with HIV are emerging. These include the adverse effects of long-term ART and morbidity due to non AIDS complications such as cardiovascular, hepatic, renal, metabolic and neurocognitive disease, cancers and ageing as well as complications due to hepatitis B and C co-infection. Although first and second-line antiretrovirals are available in resource-limited settings, new antiretrovirals are urgently needed in order to sustain HIV as a chronic manageable condition. (Source: International Journal of Infectious Diseases)

Egypt experience in treating HCV
Tue, 29 Mar 2016 09:23:40 +0100 | International Journal of Infectious Diseases
Abstract: Infection with HIV and HCV contributes substantially to the global burden of disease, with an estimated 4-5 million people living with both infections. The natural history of HIV and HCV is significantly impacted by the coexistence of the other virus. Increases in all-cause, AIDS-related, and liver-related morbidity, hospitalization, and mortality are noted, with accelerated liver disease progression and high rates of end-stage liver disease, even in those receiving combination antiretroviral therapy (cART) Given greater access to cART, the number of global deaths related to HIV is falling. (Source: International Journal of Infectious Diseases)

India - National disaster and epidemic preparedness
Tue, 29 Mar 2016 09:23:40 +0100 | International Journal of Infectious Diseases
Abstract: History provides us several illustrations where epidemic outbreaks have led to biological disasters. Accidental or deliberate release of harmful micro-organisms can also lead to biological disasters. With the advent of bio-terrorism, there is a growing realisation that biological agents can also be used as weapons of mass destruction. The spread of Spanish Influenza of 1917-18, the Human Immunodeficiency Virus (HIV) / Acquired Immuno Deficiency Syndrome (AIDS), Severe Acute Respiratory Syndrome (SARS), Swine Flu (H1N1), Avian Influenza (H5N1), Middle East Respiratory Syndrome (MERS), dengue, chikunguniya, Ebola outbreak in West Africa and the recent Zika outbreak in several countries tested the capacities of the public health delivery system in several countries. (Source: Interna...

Attitude toward quoting research evidence in technical guidelines on the Nigeria HIV/AIDS program
Tue, 29 Mar 2016 09:23:39 +0100 | International Journal of Infectious Diseases
Background: In 2013 Nigeria was home to 9% of PLHIV, 10% of new infections and 14% of AIDS related deaths. HIV programs are directed by relevant evidence based National guidelines; providers in Nigeria have however continued to use various guidelines for patient management, stating the availability of evidence based research from various sources in other guidelines. (Source: International Journal of Infectious Diseases)

Adherence to antiretroviral drug treatment ARV among people living with HIV/AIDS: A study from Eastern Nepal
Tue, 29 Mar 2016 09:23:39 +0100 | International Journal of Infectious Diseases
This study aimed to determine adherence to ART and identify associated factors with adherence among people with HIV/AIDS and receiving ART/ARV therapy. (Source: International Journal of Infectious Diseases)

APAIDSON program evaluation of the largest private public partnership consortium for HIV/AIDS care and treatment in India
Tue, 29 Mar 2016 09:23:38 +0100 | International Journal of Infectious Diseases
Background: In India, private institutions were not involved in the activities of National AIDS Control Program (NACP). Andhra Pradesh AIDS Consortium (APAIDSCON) the largest public health partnership a network of 20 medical colleges established to address HIV AIDS in India was spearheaded by SHARE India and funded in part by United States Centers for Disease Control & Prevention Cooperative agreement # U62/CCU025160-02. 2005 –2010. A program evaluation based on CDC Project Evaluation protocols was undertaken in 2013-14 to evaluate APAIDSCON results. (Source: International Journal of Infectious Diseases)

Cryptococcus meningitis and the genotypes of cryptococcus neoformans prevalent in Western Maharashtra, India
Tue, 29 Mar 2016 09:23:37 +0100 | International Journal of Infectious Diseases
Background: Cryptococcal meningitis is an AIDs defining illness. However the disease is seen in patients without HIV infection also. Attempts have been made to develop a vaccine for the disease, so the prevalent genotypes of Cryptococcal neoformans need to be identified. In the Indian scenario there is a paucity of literature on MLST genotyping. Genotyping of C. neoformans can be performed for epidemiological purpose, to determine whether the cryptococcosis is caused by single genotype or two or more genotypes and to develop vaccine production. (Source: International Journal of Infectious Diseases)

Health related quality of life of HIV/AIDS patients on highly active antiretroviral therapy in Ahmadu Bello University Teaching Hospital
Tue, 29 Mar 2016 09:23:37 +0100 | International Journal of Infectious Diseases
This study aims to determine the health related quality of life of HIV/AIDS patients on HAART at Ahmadu Bello University Teaching Hospital (ABUTH) Zaria. (Source: International Journal of Infectious Diseases)